David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Ezio Di Nucci
Jonathan Jenkins Ichikawa
Jack Alan Reynolds
Learn more about PhilPapers
Journal of Philosophical Research 32 (Supplement):345-356 (2007)
In this paper I state and reject two of the most commonly given arguments for regulating access by insurance companies to the results of genetic tests. I then argue that since we cannot assume a priori that those genetically predisposed to disease will have worse health outcomes than those not so disposed, we cannot know a priori that genetic discrimination will emerge as a major problem in a free market health insurance system. Finally, I explore the possibility of a free-market solution to the problem of genetic discrimination:genetic insurance
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
No references found.
Citations of this work BETA
No citations found.
Similar books and articles
Joseph S. Alper & Jon Beckwith (1998). Distinguishing Genetic From Nongenetic Medical Tests: Some Implications for Antidiscrimination Legislation. Science and Engineering Ethics 4 (2):141-150.
V. Launis (2000). The Use of Genetic Test Information in Insurance: The Argument From Indistinguishability Reconsidered. Science and Engineering Ethics 6 (3):299-310.
Shaheen Borna & Stephen Avila (1999). Genetic Information: Consumers' Right to Privacy Versus Insurance Companies' Right to Know a Public Opinion Survey. [REVIEW] Journal of Business Ethics 19 (4):355 - 362.
Felix Thiele (2003). Genetic Tests in the Insurance System: Criteria for a Moral Evaluation. Poiesis and Praxis 1 (3):185-195.
B. M. Kious (2010). Genetic Nondiscrimination and Health Care as an Entitlement. Journal of Medicine and Philosophy 35 (2):86-100.
Cormac Nagle (2010). Genetic Testing and Insurance. Chisholm Health Ethics Bulletin 15 (4):9.
Ruth Hannah Wilkinson (2010). Genetic Information: Important but Not “Exceptional”. [REVIEW] Identity in the Information Society 3 (3):457-472.
Eli Feiring (2009). Reassessing Insurers' Access to Genetic Information: Genetic Privacy, Ignorance, and Injustice. Bioethics 23 (5):300-310.
Antoinette Rouvroy (2008). Human Genes and Neoliberal Governance: A Foucauldian Critique. Routledge-Cavendish.
Ludvig Beckman (2004). Are Genetic Self-Tests Dangerous? Assessing the Commercialization of Genetic Testing in Terms of Personal Autonomy. Theoretical Medicine and Bioethics 25 (5-6):387-398.
Patrick L. Brockett & E. Susan Tankersley (1997). The Genetics Revolution, Economics, Ethics and Insurance. Journal of Business Ethics 16 (15):1661-1676.
P. J. Malpas (2008). Is Genetic Information Relevantly Different From Other Kinds of Non-Genetic Information in the Life Insurance Context? Journal of Medical Ethics 34 (7):548-551.
Nancy S. Jecker (1993). Genetic Testing and the Social Responsibility of Private Health Insurance Companies. Journal of Law, Medicine & Ethics 21 (1):109-116.
Nancy Kass & Amy Medley (2007). Genetic Screening and Disability Insurance: What Can We Learn From The Health Insurance Experience? Journal of Law, Medicine & Ethics 35 (s2):66-73.
Paul Steven Miller (2007). Genetic Testing and the Future of Disability Insurance: Thinking About Discrimination in the Genetic Age. Journal of Law, Medicine & Ethics 35 (s2):47-51.
Added to index2011-12-02
Total downloads13 ( #284,960 of 1,934,701 )
Recent downloads (6 months)1 ( #434,264 of 1,934,701 )
How can I increase my downloads?